Coastal Infusion Administers Keytruda®
| J-Code | J9271 |
|---|---|
| Manufacturer | Merck |
| First Approved | 10/24/2016 |
Coastal Infusion can administer your Keytruda prescription at any of our south Florida locations.
Keytruda (pembrolizumab) is used in the treatment of various cancers, particularly those that express elevated levels of PD-L1 (programmed death-ligand 1) and are associated with microsatellite instability (MSI) or mismatch repair deficiency (dMMR).
The active substance in Keytruda, pembrolizumab, is a monoclonal antibody, a protein that has been designed to recognize and block a receptor called PD-1. By blocking PD-1, pembrolizumab stops the cancer from switching off these immune cells, thereby increasing the immune system’s ability to kill the cancer cells.
What It Treats
- Triple-negative breast cancer (TNBC)
- Non-small cell lung cancer (NSCLC)
- Melanoma and cutaneous squamous cell carcinoma (cSCC)
- Cervical cancer
- Esophageal and Stomach cancers
- Other cancers
Prescribed By
Keytruda is most often prescribed by Oncologists and some other specialists.
How it’s Administered
Keytruda is administered by intravenous infusion. Keytruda infusions take about 30 minutes.
Frequency
Keytruda is generally administered every four weeks.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies